Lower extremity outcome measures: considerations for clinical trials in spinal cord injury
Marc Bolliger(Universitätsklinik Balgrist), John D. Steeves(University of British Columbia), Chris Awai Easthope(University of Lucerne), Linda Jones(Craig H Neilsen Foundation), Dorothy Barthélemy(Centre for Interdisciplinary Research in Rehabilitation), Giorgio Scivoletto(Fondazione Santa Lucia), Daniel P. Lammertse(Craig Hospital), Michael L. Boninger(University of Pittsburgh), Björn Zörner(Universitätsklinik Balgrist), Andrew R. Blight(Acorda Therapeutics (United States)), Dirk Haupt(University of British Columbia), Sylvie Nadeau(Université Laval), R. Rupp(Heidelberg University), Dany H. Gagnon(Université du Québec à Montréal), Kristin E. Musselman(Queen's University), Edelle C. Field‐Fote(Georgia Institute of Technology), Jan M. Schwab(The Ohio State University Wexner Medical Center), Lea Awai(Universitätsklinik Balgrist), Naomi Kleitman, Armin Curt(Universitätsklinik Balgrist), Laurent J. Bouyer(Université Laval), Miloš R. Popović(University of Toronto), Serge Rossignol(Université de Montréal), Keith E. Tansey(Jackson Memorial Hospital)
Cited by 53
Related Papers
Central nervous system injury-induced immune deficiency syndrome
|Nature reviews. Neuroscience|2005|948
N‐methyl‐<scp>D</scp>‐aspartate receptor antibodies in herpes simplex encephalitis
|Annals of Neurology|2012|414
Hypoxia-inducible factor–dependent induction of netrin-1 dampens inflammation caused by hypoxia
|Nature Immunology|2009|403
The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar
|Molecular and Cellular Neuroscience|2003|401